Ronald Dahl Selected Research

Ronald Dahl Research Topics

Disease

28	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 07/2004
25	Asthma (Bronchial Asthma) 07/2020 - 03/2006
11	Hypersensitivity (Allergy) 01/2017 - 01/2006
5	Allergic Rhinitis 01/2017 - 01/2003
5	Dyspnea (Shortness of Breath) 01/2016 - 05/2005
4	Inflammation (Inflammations) 01/2020 - 07/2004
3	Seasonal Allergic Rhinitis (Hay Fever) 01/2021 - 04/2015
3	Airway Obstruction (Choking) 01/2016 - 07/2004
1	Respiratory Hypersensitivity 01/2020
1	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2017
1	AIDS-Related Complex (ARC) 03/2016
1	Nasopharyngitis 01/2016
1	Heart Diseases (Heart Disease) 01/2016
1	Perennial Allergic Rhinitis 04/2015
1	Pneumonia (Pneumonitis) 10/2014
1	Atrial Flutter (Flutter, Atrial) 10/2014
1	Exanthema (Rash) 01/2014
1	Angioedema 01/2014
1	Urticaria (Hives) 01/2014
1	Hyperventilation 10/2013
1	Dust Mite Allergy 06/2011
1	Cataract (Cataracts) 08/2006
1	Conjunctivitis 01/2003

Drug/Important Bio-Agent (IBA)

19	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2020 - 01/2003
19	Bronchodilator Agents (Bronchodilators)IBA 06/2020 - 07/2004
16	Tiotropium Bromide (Spiriva)FDA Link 01/2017 - 09/2012
9	indacaterolIBA 06/2015 - 10/2007
7	Fluticasone (Cutivate)FDA LinkGeneric 06/2020 - 03/2006
7	AllergensIBA 02/2016 - 01/2006
6	GoldIBA 01/2018 - 01/2013
5	Muscarinic AntagonistsIBA 06/2020 - 01/2013
4	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 03/2016 - 01/2013
4	Cholinergic Antagonists (Anticholinergics)IBA 03/2016 - 04/2013
4	Salmeterol Xinafoate (Serevent)FDA Link 10/2014 - 07/2006
3	TabletsIBA 03/2016 - 01/2010
3	Immunoglobulin E (IgE)IBA 02/2016 - 01/2014
3	Methotrexate (Mexate)FDA LinkGeneric 06/2015 - 01/2014
3	indacaterol-glycopyrronium combinationIBA 10/2014 - 01/2013
3	Formoterol Fumarate (Oxis)FDA Link 02/2013 - 07/2006
3	ciclesonide FDA Link 08/2010 - 03/2006
2	GSK573719IBA 06/2020 - 03/2016
2	Vitamin D FDA LinkGeneric 03/2016 - 06/2015
2	MagnesiumIBA 03/2016 - 06/2015
2	Histamine Antagonists (Antihistamines)IBA 04/2015 - 01/2003
2	GlucocorticoidsIBA 10/2014 - 09/2012
2	SteroidsIBA 04/2014 - 07/2008
2	GrazaxIBA 03/2012 - 01/2010
2	Budesonide (Pulmicort)FDA LinkGeneric 07/2006 - 03/2006
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 08/2017
1	ORALIT (ORS)IBA 08/2017
1	Olive OilIBA 01/2017
1	Fish OilsIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	PowdersIBA 10/2016
1	Immunoglobulin G (IgG)IBA 02/2016
1	Eosinophil Cationic ProteinIBA 07/2015
1	hydroxide ionIBA 07/2015
1	CalciumIBA 06/2015
1	Cholecalciferol (Vitamin D3)FDA Link 06/2015
1	azelastine (Optivar)FDA LinkGeneric 04/2015
1	MP29-02IBA 04/2015
1	omega-Chloroacetophenone (Mace)IBA 10/2014
1	Penicillins (Penicillin)FDA Link 01/2014
1	Prednisolone (Predate)FDA LinkGeneric 01/2014
1	GasesIBA 10/2013
1	AcidsIBA 10/2013
1	DesmosineIBA 04/2012
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	Matrix Metalloproteinases (MMPs)IBA 04/2012
1	4- ((5- chloro- 2- pyridinyl)oxy)- 1- ((((4S)- 4- methyl- 2,5- dioxo- 4- imidazolidinyl)methyl)sulfonyl)- piperidineIBA 04/2012
1	Interleukin-6 (Interleukin 6)IBA 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2004
1	Protease Inhibitors (Protease Inhibitor)IBA 07/2004
1	Peptide Hydrolases (Proteases)FDA Link 07/2004
1	Cholinergic Agents (Cholinergics)IBA 07/2004
1	Interleukin-8 (Interleukin 8)IBA 07/2004

Therapy/Procedure

13	Therapeutics 07/2020 - 07/2004
10	Immunotherapy 01/2021 - 11/2009
6	Nebulizers and Vaporizers (Inhaler) 01/2017 - 09/2012
2	Homeopathy 07/2020 - 01/2020
2	Musculoskeletal Manipulations (Manipulative Therapy) 07/2020 - 01/2020
2	Complementary Therapies (Alternative Medicine) 07/2020 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2016 - 04/2015
1	Duration of Therapy 01/2015
1	Intravenous Infusions 10/2011
1	Aftercare (After-Treatment) 01/2010
1	Subcutaneous Injections 01/2010
1	Ambulatory Care (Outpatient Care) 07/2008
1	Nursing Care 05/2005